<DOC>
	<DOC>NCT03091062</DOC>
	<brief_summary>The aim of this study is to assess the effectiveness of an Airway Clearance System.</brief_summary>
	<brief_title>Evaluation of an Airway Clearance System</brief_title>
	<detailed_description>The study will compare the effectiveness of The Monarch™ System and The Vest® Airway Clearance System. All subjects will receive treatment with both systems and endpoints will be compared.</detailed_description>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Documented diagnosis of Cystic Fibrosis (CF) (by sweat test and/or genetics) Age ≥ 15 years Ability to expectorate sputum daily determined by treating physician Patient must be on a stable regimen of CF medication for 4 weeks Patient who requires regular home airway clearance therapy Forced Expiratory Volume in 1 Second (FEV1) &lt; 30 % predicted or &gt; 90 % predicted Anticipated requirement for hospitalization within the next three weeks History of pneumothorax within the past 6 months prior History of haemoptysis requiring embolization within the past 12 months Inability to perform Monarch™ and/or Vest® System therapy as directed Unable or unwilling to complete study visits or provide followup data as required per the study protocol Has taken Intravenous (IV) antibiotics within the past 4 weeks prior to Visit 1 Has ongoing exacerbation or Allergic bronchopulmonary aspergillosis (ABPA) Pregnant or lactating female</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>